CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00323583
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:34:51.270750+00:00
- Published At
- 2007-05-08T00:00:00+00:00
- Record Updated At
- 2007-05-08
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Adenocarincoma of Pancreas", "Stage III Pancreatic Cancer", "Stage IVA Pancreatic Cancer", "Stage IVB Pancreatic Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2007-05-08"- protocolSection.identificationModule.nctId
"NCT00323583"- protocolSection.identificationModule.officialTitle
"Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.